Brussels, 04/11/2013 (Agence Europe) - Providing novel treatments that are more adapted to target groups of patients is the aim of personalised medicine, an area that has enormous potential. On 31 October, the European Commission published a report assessing the progress made in the field of personalised medicine, its advantages and the challenges it faces.
The report focuses on three points: 1) the potential of so-called “omic” technologies such as genomic and large scale DNA...